Health care stocks were lower Thursday afternoon, with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.7%.
The iShares Biotechnology ETF (IBB) fell 0.8%.
In corporate news, Bausch + Lomb (BLCO) said a go-private deal with a third-party buyer won't materialize at this time. The deal was one of the options being explored to complete a full separation from Bausch Health (BHC), it said. Bausch + Lomb shares fell 8.5%, and Bausch Health was down 8.3%.
Prestige Consumer Healthcare (PBH) shares jumped 13% after its fiscal Q3 adjusted earnings and revenue came in ahead of analysts' estimates.
Globus Medical (GMED) and Nevro (NVRO) said Thursday that Globus has agreed to buy Nevro in all-cash deal valued at $250 million. Globus shares fell 4% and Nevro surged 14%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。